Click here for the CME evaluation / post-test

Activity Index
Click on the titles below to view the presentations.

Pre-conference program: Challenges in breast cancer nursing

Genetics of breast cancer risk
Brittany Thomas, MS, CGC

Surgical advances and management of complications
Deborah Feigel, PA

Breast cancer: Oral drug adherence
Frances Palmieri, RN, MSN, OCN

Nursing care of the patient receiving radiation therapy
Heidi Schulz, RN, OCN

The impact of breast cancer and its treatment on families
Alisha Stein RN, MSN, OCN

General Sessions

Session I: Breast cancer: Prevention, detection, and prognosis

Chemoprevention strategies: assessing risk of breast cancer and choice of agent
Victor G. Vogel, MD

Genetic profiling in breast cancer
Joseph A. Sparano, MD

Vaccines: novel tools to prevent breast cancer recurrence
Lupe G. Salazar, MD

Session II: Surgery/Radiotherapy

Breast-conserving therapy after neoadjuvant chemotherapy
Lisa Newman, MD

Radiation in DCIS: Weighing the risk and benefits
Abram Recht, MD

Accelerated partial breast irradiation
Frank A Vicini, MD

Alternatives to axillary dissection for patients with positive sentinel nodes: interactive cases
Abram Recht, MD

Micrometastases: evaluating their significance and management
Richard J. Gray, MD

Day 2

Session III: Early and locally advanced disease

Optimizing taxane regimens in node-positive patients
Harold J Burstein, MD

Adjuvant hormonal therapy in postmenopausal women
Harold J Burstein, MD

Current guidelines and new strategies for treating early HER2 positive patients
Edith A. Perez, MD

New studies of anti-angiogenesis agents in early breast cancer
Maura N. Dickler, MD

Pharmacogenomics of tamoxifen and aromatase inhibitor therapy
Vered Stearns

Session IV: Disease management

Managing the side effects of hormonal therapy
Charles L. Loprinzi, MD

Treatment-related cardiac toxicity
Alphonse Taghian, MD, PhD

Session V: Metastatic and inflammatory breast cancer

Update on novel targeted therapies as monotherapeutic agents or
with chemotherapy for metastatic/refractory disease
Kevin Fox, MD

Lapatinib for inflammatory and trastuzumab-resistant breast cancer
Kevin Fox, MD

Role of hormonal therapy as single agent or in combination with other agents in advanced disease
Ruth O'Regan, MD

Click here for the CME evaluation / post-test